Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Precision psychiatry: The complexity of personalizing antipsychotic dosing
José de León
European Neuropsychopharmacology (2022) Vol. 58, pp. 80-85
Closed Access | Times Cited: 9

Showing 9 citing articles:

Reflections on the Lack of Consideration of Ethnic Ancestry to Stratify Clozapine Dosing
José de León
Psychiatry Investigation (2023) Vol. 20, Iss. 3, pp. 183-195
Open Access | Times Cited: 24
A New Intervention for Implementation of Pharmacogenetics in Psychiatry: A Description of the PSY-PGx Clinical Study
Teuntje A. D. Pelgrim, Alexandra Philipsen, Allan H. Young, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 151-151
Open Access | Times Cited: 8
Immunoinflammatory and oxidative alterations in subjects with schizophrenia under clozapine: A meta-analysis
Paulo Levi Bezerra Martins, Ian Araújo Moura, Gabrielle Mendes, et al.
European Neuropsychopharmacology (2023) Vol. 73, pp. 82-95
Closed Access | Times Cited: 12
A Review of Clinical Advances and Challenges in Clozapine-Induced Myocarditis
Mier Li, Yuncheng Bai, Yanjun Wang, et al.
Neuropsychiatric Disease and Treatment (2025) Vol. Volume 21, pp. 525-538
Open Access
Perspectives on Precision Psychiatry Using Antipsychotics in the Management of Bipolar Disorder
Michele Fornaro, Alessandro Miola, Domenico De Berardis, et al.
Brain Sciences (2025) Vol. 15, Iss. 5, pp. 430-430
Open Access
Rare variants in pharmacogenes influence clozapine metabolism in individuals with schizophrenia
Djenifer B. Kappel, Elliott Rees, Eilidh Fenner, et al.
European Neuropsychopharmacology (2024) Vol. 80, pp. 47-54
Open Access | Times Cited: 3
The history of clozapine in clinical practice: From its introduction to a guideline proposing personalized titrations
José de León
Journal of Psychopharmacology (2022) Vol. 36, Iss. 6, pp. 657-660
Closed Access | Times Cited: 13
Comparing the pharmacology and pharmacokinetics of antipsychotics: Choosing an antipsychotic and dosing a long-acting injectable
Stephen M. Stahl, G. Djokic
European Neuropsychopharmacology (2023) Vol. 73, pp. 108-118
Closed Access | Times Cited: 3
A Chinese medicine called Danggui Longhui may be a new clinically relevant clozapine inducer: Two case reports identified by therapeutic drug monitoring
Fei Jia, Yannan Zang, Can‐Jun Ruan, et al.
Schizophrenia Research (2023) Vol. 268, pp. 308-311
Closed Access | Times Cited: 3
Polypharmacotherapy in Psychiatry: Global Insights from a Rapid Online Survey of Psychiatrists
Michał Ordak, Daria Tkacz, Aniela Golub, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 8, pp. 2129-2129
Open Access
Page 1

Scroll to top